Literature DB >> 35709709

Rise of the Clones: Myelodysplastic Syndrome to Secondary Acute Myeloid Leukemia.

Kyle A Romine1, Peter van Galen2.   

Abstract

Myelodysplastic syndrome (MDS) describes a family of blood disorders driven by the clonal expansion of mutated blood cells that can evolve into secondary acute myeloid leukemia (sAML). Two new studies use single-cell and deep sequencing to elucidate the progression of MDS to AML, revealing discrete clonal architectures and the driving role of signaling mutations. ©2022 American Association for Cancer Research.

Entities:  

Mesh：

Year:  2022        PMID： 35709709      PMCID： PMC9338726          DOI： 10.1158/2643-3230.BCD-22-0046

Source DB:  PubMed          Journal:  Blood Cancer Discov        ISSN： 2643-3230


  10 in total

1.  Clonal architecture of secondary acute myeloid leukemia.

Authors:  Matthew J Walter; Dong Shen; Li Ding; Jin Shao; Daniel C Koboldt; Ken Chen; David E Larson; Michael D McLellan; David Dooling; Rachel Abbott; Robert Fulton; Vincent Magrini; Heather Schmidt; Joelle Kalicki-Veizer; Michelle O'Laughlin; Xian Fan; Marcus Grillot; Sarah Witowski; Sharon Heath; John L Frater; William Eades; Michael Tomasson; Peter Westervelt; John F DiPersio; Daniel C Link; Elaine R Mardis; Timothy J Ley; Richard K Wilson; Timothy A Graubert
Journal:  N Engl J Med       Date:  2012-03-14       Impact factor: 91.245

2.  Tracing the origins of relapse in acute myeloid leukaemia to stem cells.

Authors:  Liran I Shlush; Amanda Mitchell; Lawrence Heisler; Sagi Abelson; Stanley W K Ng; Aaron Trotman-Grant; Jessie J F Medeiros; Abilasha Rao-Bhatia; Ivana Jaciw-Zurakowsky; Rene Marke; Jessica L McLeod; Monica Doedens; Gary Bader; Veronique Voisin; ChangJiang Xu; John D McPherson; Thomas J Hudson; Jean C Y Wang; Mark D Minden; John E Dick
Journal:  Nature       Date:  2017-06-28       Impact factor: 49.962

3.  Dynamics of clonal evolution in myelodysplastic syndromes.

Authors:  Hideki Makishima; Tetsuichi Yoshizato; Kenichi Yoshida; Mikkael A Sekeres; Tomas Radivoyevitch; Hiromichi Suzuki; Bartlomiej Przychodzen; Yasunobu Nagata; Manja Meggendorfer; Masashi Sanada; Yusuke Okuno; Cassandra Hirsch; Teodora Kuzmanovic; Yusuke Sato; Aiko Sato-Otsubo; Thomas LaFramboise; Naoko Hosono; Yuichi Shiraishi; Kenichi Chiba; Claudia Haferlach; Wolfgang Kern; Hiroko Tanaka; Yusuke Shiozawa; Inés Gómez-Seguí; Holleh D Husseinzadeh; Swapna Thota; Kathryn M Guinta; Brittney Dienes; Tsuyoshi Nakamaki; Shuichi Miyawaki; Yogen Saunthararajah; Shigeru Chiba; Satoru Miyano; Lee-Yung Shih; Torsten Haferlach; Seishi Ogawa; Jaroslaw P Maciejewski
Journal:  Nat Genet       Date:  2016-12-19       Impact factor: 38.330

4.  Convergent Clonal Evolution of Signaling Gene Mutations Is a Hallmark of Myelodysplastic Syndrome Progression.

Authors:  Andrew J Menssen; Ajay Khanna; Christopher A Miller; Sridhar Nonavinkere Srivatsan; Gue Su Chang; Jin Shao; Joshua Robinson; Michele O'Laughlin; Catrina C Fronick; Robert S Fulton; Kimberly Brendel; Sharon E Heath; Raya Saba; John S Welch; David H Spencer; Jacqueline E Payton; Peter Westervelt; John F DiPersio; Daniel C Link; Matthew J Schuelke; Meagan A Jacoby; Eric J Duncavage; Timothy J Ley; Matthew J Walter
Journal:  Blood Cancer Discov       Date:  2022-07-06

5.  Distinct Patterns of Clonal Evolution Drive Myelodysplastic Syndrome Progression to Secondary Acute Myeloid Leukemia.

Authors:  Tiffany Guess; Chad R Potts; Pawan Bhat; Justin A Cartailler; Austin Brooks; Clinton Holt; Ashwini Yenamandra; Ferrin C Wheeler; Michael R Savona; Jean-Philippe Cartailler; P Brent Ferrell
Journal:  Blood Cancer Discov       Date:  2022-07-06

6.  Clonal diversity of recurrently mutated genes in myelodysplastic syndromes.

Authors:  M J Walter; D Shen; J Shao; L Ding; B S White; C Kandoth; C A Miller; B Niu; M D McLellan; N D Dees; R Fulton; K Elliot; S Heath; M Grillot; P Westervelt; D C Link; J F DiPersio; E Mardis; T J Ley; R K Wilson; T A Graubert
Journal:  Leukemia       Date:  2013-02-27       Impact factor: 11.528

Review 7.  An evolutionary approach to clonally complex hematologic disorders.

Authors:  Emily Schwenger; Ulrich Steidl
Journal:  Blood Cancer Discov       Date:  2021-04-15

8.  Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level.

Authors:  Jiahao Chen; Yun-Ruei Kao; Daqian Sun; Tihomira I Todorova; David Reynolds; Swathi-Rao Narayanagari; Cristina Montagna; Britta Will; Amit Verma; Ulrich Steidl
Journal:  Nat Med       Date:  2018-12-03       Impact factor: 53.440

9.  Clonal architecture predicts clinical outcomes and drug sensitivity in acute myeloid leukemia.

Authors:  Brooks A Benard; Logan B Leak; Armon Azizi; Daniel Thomas; Andrew J Gentles; Ravindra Majeti
Journal:  Nat Commun       Date:  2021-12-13       Impact factor: 14.919

10.  Single-cell mutation analysis of clonal evolution in myeloid malignancies.

Authors:  Linde A Miles; Robert L Bowman; Ross L Levine; Tiffany R Merlinsky; Isabelle S Csete; Aik T Ooi; Robert Durruthy-Durruthy; Michael Bowman; Christopher Famulare; Minal A Patel; Pedro Mendez; Chrysanthi Ainali; Benjamin Demaree; Cyrille L Delley; Adam R Abate; Manimozhi Manivannan; Sombeet Sahu; Aaron D Goldberg; Kelly L Bolton; Ahmet Zehir; Raajit Rampal; Martin P Carroll; Sara E Meyer; Aaron D Viny
Journal:  Nature       Date:  2020-10-28       Impact factor: 49.962
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.